ALPS Medical Breakthroughs ETF

-$0.07 (-0.16%) As of 3:53 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SBIO and other ETFs, options, and stocks.

About SBIO

SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.

What's in this fund

Sectors

As of December 6, 2021
Healthcare100.00%

Top 10 Holdings (27.78% of total assets)

As of December 7, 2021
Name
Symbol
% Assets
Legend Biotech
LEGN
4.59%
Vir Biotechnology
VIR
3.60%
Cerevel Therapeutics
CERE
3.11%
Kodiak Sciences
KOD
2.97%
Karuna Therapeutics
KRTX
2.37%
Alkermes
ALKS
2.33%
Apellis Pharmaceuticals
APLS
2.31%
SpringWorks
SWTX
2.20%
ACADIA Pharmaceuticals
ACAD
2.20%
Arcus Biosciences
RCUS
2.10%

SBIO Key Statistics

AUM
177.66M
Price-Earnings ratio
-11.89
30-Day yield
-0.49
Average volume
28.18K
High today
$42.71
Low today
$42.29
Open price
$42.43
Volume
6.00K
52 Week high
$64.04
52 Week low
$39.55
Expense ratio
0.50

Average Annual Return

1Y3Y5Y10YSince
Dec 30, 2014
% Price Return-12.61%9.57%13.23%
—
8.95%
% NAV Return-12.37%9.57%13.24%
—
9.60%
As of November 30, 2021
All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. Current performance may be lower or higher than the performance data quoted. Full disclosure